Literature DB >> 28208146

Serum Lipid Fractions and Cerebral Microbleeds in a Healthy Japanese Population.

Shingo Mitaki1, Atsushi Nagai, Hiroaki Oguro, Shuhei Yamaguchi.   

Abstract

BACKGROUND: Cerebral microbleeds (CMBs) are associated with focal hemosiderin deposits and represent a form of cerebral small vessel disease. To date, indefinite and inconsistent reports are available regarding the association between serum lipid fractions and CMBs. In addition, these previous studies did not include Asian populations, who may have a higher risk of cerebral hemorrhage. The purpose of this study was to examine the associations between serum lipid fractions and CMBs in healthy Japanese subjects.
METHODS: We performed a cross-sectional study involving 4,024 neurologically normal Japanese subjects (mean age 61.6 years). All the participants underwent 1.5-Tesla magnetic resonance imaging scan, and CMBs were classified into 3 groups based on their locations. The concentrations of lipid fractions were categorized into quartiles and the association between the lipid fractions and CMBs were investigated using logistic regression analysis.
RESULTS: CMBs were observed in 164 (4.1%) of participants. Of these participants with CMBs, 33 (20.1%) had lobar CMBs and 91 (55.5%) had deep CMBs. Subjects with deep CMBs had lower total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) levels. After adjusting for confounding factors, lower TC and HDL-C levels were still associated with the presence of deep CMBs (OR for the highest vs. the lowest quartiles of TC and HDL-C was 2.28 [95% CI 1.05-4.94], and 1.93 [95% CI 1.02-3.65], respectively). The presence of subcortical infarcts and periventricular hyperintensities was more frequently observed in deep CMBs, whereas white matter hyperintensities were more frequently observed in lobar CMBs.
CONCLUSIONS: Our results suggest that low serum TC and HDL-C levels are closely associated with deep CMBs.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28208146     DOI: 10.1159/000456623

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly.

Authors:  Weike Liu; Jing Xu; Huajing Song; Chunju Zhang; Yanli Yao; Hua Zhang; Yue-Chun Li; Zhendong Liu
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

2.  Metabolic syndrome is associated with incidence of deep cerebral microbleeds.

Authors:  Shingo Mitaki; Hiroyuki Takayoshi; Tomonori Nakagawa; Atsushi Nagai; Hiroaki Oguro; Shuhei Yamaguchi
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

3.  Cerebral microbleeds and acute myocardial infarction: Screening and disease progression.

Authors:  Abbass Alaa El Din; Hugo Debeaumarche; Pierre Thouant; Maud Maza; Frédéric Ricolfi; Marianne Zeller; Florence Bichat; Nathalie Baudouin; Yannick Bejot; Yves Cottin
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-29

Review 4.  Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies.

Authors:  Alvin S Das; Robert W Regenhardt; Meike W Vernooij; Deborah Blacker; Andreas Charidimou; Anand Viswanathan
Journal:  J Stroke       Date:  2019-04-17       Impact factor: 6.967

5.  Subsequent bilateral intracerebral hemorrhages in the putamen and thalamus: A report of four cases.

Authors:  Satoshi Tsutsumi; Kiyotaka Kuroda; Hiroki Sugiyama; Natsuki Sugiyama; Hideaki Ueno; Hisato Ishii
Journal:  Surg Neurol Int       Date:  2022-09-02

6.  Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community.

Authors:  Tomohiro Yubi; Jun Hata; Tomoyuki Ohara; Naoko Mukai; Yoichiro Hirakawa; Daigo Yoshida; Seiji Gotoh; Naoki Hirabayashi; Yoshihiko Furuta; Tetsuro Ago; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Neurol Clin Pract       Date:  2018-06

7.  Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age.

Authors:  Yuqi Guo; Yunpeng Li; Xukui Liu; Yi Cui; Yingxin Zhao; Shangwen Sun; Qing Jia; Qiang Chai; Gary Gong; Hua Zhang; Zhendong Liu
Journal:  BMC Geriatr       Date:  2020-08-17       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.